About
Oral Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
4
As Collaborator
4
Total Enrollment
753
By Phase
PHASE2/PHASE3: 1PHASE3: 2PHASE1: 4PHASE1/PHASE2: 1
By Status
COMPLETED: 5RECRUITING: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06388083Lead Sponsor
A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease
PHASE2/PHASE3Recruiting
60 participants
Started: Jul 31, 2024 · Completed: Jan 31, 2028
NCT05949593Lead Sponsor
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
PHASE3Recruiting
429 participants
Started: Jul 27, 2023 · Completed: Nov 30, 2027
NCT05667688Collaborator
Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85
PHASE1Completed
15 participants
Started: Nov 28, 2022 · Completed: Jan 18, 2023
NCT05244304Lead Sponsor
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease
PHASE3Active, not recruiting
104 participants
Started: Mar 28, 2022 · Completed: Oct 31, 2025
NCT05266014Collaborator
This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
PHASE1/PHASE2Completed
13 participants
Started: Mar 12, 2021 · Completed: Aug 15, 2023
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...